๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Senescence and pre-malignancy: How do tumors progress?

โœ Scribed by Raya Saab


Book ID
113900524
Publisher
Elsevier Science
Year
2011
Tongue
English
Weight
304 KB
Volume
21
Category
Article
ISSN
1044-579X

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Diversification and progression of malig
โœ Garth L. Nicolson; Nancy L. Rosenberg ๐Ÿ“‚ Article ๐Ÿ“… 1987 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 641 KB

Tumor-cell diversification mechanisms insure that malignant neoplasms contain diversijied tumor-cell subpopulations. Because of the instability of tumor cell phenotypes, some malignant cells will evolve with the most favorable properties for their progression to highly metastatic cells. The rates of

Tumor recurrence and malignant progressi
โœ Michael Majores; Marec von Lehe; Jana Fassunke; Johannes Schramm; Albert J. Beck ๐Ÿ“‚ Article ๐Ÿ“… 2008 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 460 KB

## Abstract ## BACKGROUND. Most gangliogliomas (GGs) are benign tumors, but tumor recurrence and malignant progression are observed in some patients. ## METHODS. The authors analyzed their experience with 4 recurrent/progressive GGs (World Health Organization [WHO] grade I), 21 tumors with atypi

Placental bone morphogenetic protein (PL
โœ Regi Thomas; Lawrence D. True; Paul H. Lange; Robert L. Vessella ๐Ÿ“‚ Article ๐Ÿ“… 2001 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 459 KB

The second most common target of prostate-cancer metastasis is bone, and the phenomenon of skeletal metastasis represents the incurable stage of disease. Histologically, skeletal metastasis from prostate cancer is distinctive due to its osteoblastic nature. The osteoblastic bone metastasis shows ext